Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

about

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

Item

http://www.wikidata.org/entity/Q42653448

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@en

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@nl

type

Item

label

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@en

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@nl

prefLabel

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@en

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@nl

P1476

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

@en

P2093

Anna Celler

http://www.w3.org/2001/XMLSchema#string

Xinchi Hou

http://www.w3.org/2001/XMLSchema#string

P2860

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.

Modelling approaches to dose estimation in children

Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images.

Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective

Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors

Long-term effects of radiation exposure on health.

Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours.

A 3D Monte Carlo Method for Estimation of Patient-specific Internal Organs Absorbed Dose for (99m)Tc-hynic-Tyr(3)-octreotide Imaging.

P2888

s40658-017-0191-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40658-017-0191-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hanna Piwowarska-Bilska

Bożena Birkenfeld

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092198905

http://www.w3.org/2001/XMLSchema#string

P698

29030760

http://www.w3.org/2001/XMLSchema#string

P932

5640560

http://www.w3.org/2001/XMLSchema#string